The GLP-1 receptor agonist also targets the region of the brain that controls hunger, and can result in reduced cravings and overall food intake
I'm trying to understand your full picture: your weight history, what you've tried before, your current health conditions, your medications, your goals, and what you're realistically willing to commit to
At the same time, if access to and insurance coverage for these medications continue to grow, it could open the door for more people to get treatment for substance use
Semaglutide (Wegovy) Injection is usually given under the skin it should not be injected into a vein or muscle
But in 2022, Eli Lilly came out of the gate with Mounjaro, an even stronger GLP-1 drug that quickly gained momentum, making Eli Lilly a new Wall Street darling as a series of supply chain bungles hurt Novos ability to produce enough of its drugs to meet demand
I think both sides probably have their points